首页> Experimental hematology> Antileukemic potency of CD19-specific T cells against chemoresistant pediatric acute lymphoblastic leukemia.

Antileukemic potency of CD19-specific T cells against chemoresistant pediatric acute lymphoblastic leukemia.

导出 LinkOut

翻译打印收藏纠错

第一作者： Alla,Dolnikov

第一单位： Cord & Marrow Transplant Facility, Kids Cancer Centre, Sydney Children's Hospital, Sydney, Australia; Faculty of Medicine, University of New South Wales, Sydney, Australia; Children's Cancer Institute Australia, Sydney, Australia. Electronic address: alla.dolnikov@sesiahs.health.nsw.gov.au.

作者： Alla,Dolnikov ^[1] ; Sylvie,Shen ^[2] ; Guy,Klamer ^[3] ; Swapna,Joshi ^[4] ; Ning,Xu ^[5] ; Lu,Yang ^[4] ; Kenneth,Micklethwaite ^[6] ; Tracey A,O'Brien ^[2]

作者单位： Cord & Marrow Transplant Facility, Kids Cancer Centre, Sydney Children's Hospital, Sydney, Australia; Faculty of Medicine, University of New South Wales, Sydney, Australia; Children's Cancer Institute Australia, Sydney, Australia. Electronic address: alla.dolnikov@sesiahs.health.nsw.gov.au. ^[1] Cord & Marrow Transplant Facility, Kids Cancer Centre, Sydney Children's Hospital, Sydney, Australia; Faculty of Medicine, University of New South Wales, Sydney, Australia; Children's Cancer Institute Australia, Sydney, Australia. ^[2] Faculty of Medicine, University of New South Wales, Sydney, Australia; Children's Cancer Institute Australia, Sydney, Australia. ^[3] Children's Cancer Institute Australia, Sydney, Australia. ^[4] Cord & Marrow Transplant Facility, Kids Cancer Centre, Sydney Children's Hospital, Sydney, Australia; Children's Cancer Institute Australia, Sydney, Australia. ^[5] Westmead Millennium Institute, University of Sydney, Sydney, Australia. ^[6]